Modeling Pediatric Leukemia in the Zebrafish to Enable Discovery of New Anti-Leukemic Compounds |
University of California, San Diego / David Traver, MD |
Innovation Grants |
2012 |
California |
Targeted Inhibition of Signaling Networks in Pediatric Glioblastoma Stem Cells |
University of California Berkeley / Erin Simonds, PhD |
Young Investigator Grants |
2013 |
California |
Defining the Role of a Novel, Developmentally Restricted Hematopoietic Stem Cell in Pediatric Leukemias |
University of California at Santa Cruz / Camilla Forsberg, PhD |
Innovation Grants |
2013 |
California |
Synergistic Activity of Anti-GD2 Antibody and CD47-Blockade for Immunotherapy of Neuroblastoma and Osteosarcoma |
The Board of Trustees of the Leland Stanford Junior University / Robbie Majzner, MD |
'A' Award Grants |
2019 |
California |
Antibody Targeted Natural Killer Cell-Derived Extracellular Vesicles for the Treatment of Childhood Acute Lymphoblastic Leukemia and Neuroblastoma |
Children’s Hospital Los Angeles / Robert Seeger, MD & Alan Wayne, MD |
Innovation Grants |
2015 |
California |
A Combinatorial Approach to Target the Tumor-Initiating and Transit Amplifying Cellular Subpopulations in Diffuse Intrinsic Pontine Glioma (DIPG) |
Stanford University / Michelle Monje, MD, PhD |
'A' Award Grants |
2011 |
California |
Single Cell Analysis of Leukemia Initiation |
Stanford University / Michael Cleary, MD |
Innovation Grants |
2015 |
California |
Identifying novel biomarkers for risk stratification in t-cell acute lymphoblastic leukemia (ALL).
|
University of California San Francisco / Michelle Hermiston, MD, PhD |
Young Investigator Grants |
2009 |
California |
Enhancing Effectiveness of Immune Checkpoint Therapy in Neuroblastoma |
Children’s Hospital Los Angeles / Shahab Asgharzadeh, MD |
Innovation Grants |
2015 |
California |
Targeting Oncogenic N-MYC Complexes in High-Risk Neuroblastoma |
The Regents of the University of California San Francisco / Bo Qiu, MD/PhD |
Young Investigator Grants |
2023 |
California |